AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACADIA PHARMACEUTICALS INC Director's Dealing 2014

Mar 11, 2014

31237_dirs_2014-03-11_1f8e4ca7-69b1-4b41-bfab-0039420abf5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2014-03-07

Reporting Person: Hacksell Uli (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-07	Stock Option (right to buy)	$27.20	A	250000	Acquired	2024-03-06	Common Stock (250000)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vest and become exercisable on March 7, 2015. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.